AIAJ ACADEMYAIAJ Academy · News desk
Source-backed reporting and practical explainers for workers, educators, small businesses, and community learners.
The lead
Stripe's reported acquisition of OpenRouter, an AI gateway startup, marks a significant milestone in the AI industry. This deal valued at over $7 billion, highlights the growing importance of AI infrastructure and its potential applications in various sectors.
Read the full storyFrom across the desk
Published Academy coverage. Dates reflect the original publication record.
Applied Computing has raised $20M to develop a foundation AI model for the oil, gas, and petrochemical industry. This AI model aims to optimize operations and improve efficiency across the entire plant.
Applied Computing has raised $20M to develop a foundation AI model for the oil, gas, and petrochemical industry. This AI model aims to optimize operations and improve efficiency across the entire plant.
The article does not specify who is directly affected.
Microsoft is training its sales team to promote its in-house AI models as more efficient and cost-effective than those of OpenAI and Anthropic. This move reflects the increasingly competitive AI landscape, where companies are vying for market share and talent.
Microsoft is training its sales team to promote its in-house AI models as more efficient and cost-effective than those of OpenAI and Anthropic. This move reflects the increasingly competitive AI landscape, where companies are vying for market share and talent.
The article does not specify who is directly affected.
Microsoft is reportedly training its sales team to emphasize the efficiency and cost-effectiveness of its in-house AI models over competitors like OpenAI and Anthropic. This move comes as the AI landscape continues to evolve with new developments and legal battles.
Microsoft is reportedly training its sales team to emphasize the efficiency and cost-effectiveness of its in-house AI models over competitors like OpenAI and Anthropic. This move comes as the AI landscape continues to evolve with new developments and legal battles.
The article does not specify who is directly affected.
OpenAI releases a light-up keyboard designed to pair with its agentic coding app, amidst a legal battle with Apple. This development shows the company's focus on AI-driven coding tools, despite ongoing hardware trade theft allegations.
OpenAI releases a light-up keyboard designed to pair with its agentic coding app, amidst a legal battle with Apple. This development shows the company's focus on AI-driven coding tools, despite ongoing hardware trade theft allegations.
The article does not specify who is directly affected.
OpenAI releases a light-up keyboard for its agentic coding app, Codex, amidst a hardware legal battle with Apple. This move showcases the company's focus on AI-powered development tools.
OpenAI releases a light-up keyboard for its agentic coding app, Codex, amidst a hardware legal battle with Apple. This move showcases the company's focus on AI-powered development tools.
The article does not specify who is directly affected.
OpenAI releases a light-up keyboard for its agentic coding app, Codex, amidst a hardware legal battle with Apple. This move marks OpenAI's first foray into hardware, designed to enhance the coding experience for developers.
OpenAI releases a light-up keyboard for its agentic coding app, Codex, amidst a hardware legal battle with Apple. This move marks OpenAI's first foray into hardware, designed to enhance the coding experience for developers.
The article does not specify who is directly affected.
Thinking Machines has launched Inkling, its first open model, after a year and a half of building AI infrastructure. This move marks a significant shift in the company's strategy, emphasizing the limitations of one-size-fits-all AI approaches.
Thinking Machines has launched Inkling, its first open model, after a year and a half of building AI infrastructure. This move marks a significant shift in the company's strategy, emphasizing the limitations of one-size-fits-all AI approaches.
The article does not specify who is directly affected.
A recent hack revealed that AI music generator Suno scraped decades of audio from YouTube, raising concerns about data privacy and ownership. This incident has significant implications for the music industry and AI development, with potential consequences for creators and consumers alike.
A recent hack revealed that AI music generator Suno scraped decades of audio from YouTube, raising concerns about data privacy and ownership. This incident has significant implications for the music industry and AI development, with potential consequences for creators and consumers alike.
The article does not specify who is directly affected.
Apple Intelligence has been approved for launch in China through a partnership with Alibaba, bringing generative AI models to Apple's operating systems. This move marks a significant expansion of Apple's AI services into one of its most important markets.
Apple Intelligence has been approved for launch in China through a partnership with Alibaba, bringing generative AI models to Apple's operating systems. This move marks a significant expansion of Apple's AI services into one of its most important markets.
The article does not specify who is directly affected.
Anthropic-backed Ode launches to accelerate enterprise AI adoption by embedding forward-deployed engineers. This move signals a shift towards implementation over just models, with potential implications for the trillion-dollar AI industry. With Anthropic's nearly $1 trillion valuation, this strategy could redefine how businesses approach AI integration.
Anthropic-backed Ode launches to accelerate enterprise AI adoption by embedding forward-deployed engineers. This move signals a shift towards implementation over just models, with potential implications for the trillion-dollar AI industry. With Anthropic's nearly $1 trillion valuation, this strategy could redefine how businesses approach AI integration.
The article does not specify who is directly affected.
Anthropic-backed Ode launches to accelerate enterprise AI adoption by embedding engineers inside companies. This strategic move highlights the growing importance of AI implementation in driving business success.
Anthropic-backed Ode launches to accelerate enterprise AI adoption by embedding engineers inside companies. This strategic move highlights the growing importance of AI implementation in driving business success.
The article does not specify who is directly affected.
Miles Wang, an OpenAI researcher, is in talks to launch an AI drug discovery startup valued at $2 billion, signaling investor interest in AI applications for life sciences. This development could revolutionize the pharmaceutical industry and pave the way for new breakthroughs in medical research.
Miles Wang, an OpenAI researcher, is in talks to launch an AI drug discovery startup valued at $2 billion, signaling investor interest in AI applications for life sciences. This development could revolutionize the pharmaceutical industry and pave the way for new breakthroughs in medical research.
The article does not specify who is directly affected.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, indicating significant investor interest in AI applications for life sciences. This development highlights the growing potential of AI in revolutionizing healthcare and pharmaceutical research.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, indicating significant investor interest in AI applications for life sciences. This development highlights the growing potential of AI in revolutionizing healthcare and pharmaceutical research.
The article does not specify who is directly affected.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, signaling significant investor interest in applying AI to life sciences. This development has the potential to revolutionize the pharmaceutical industry and improve healthcare outcomes.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, signaling significant investor interest in applying AI to life sciences. This development has the potential to revolutionize the pharmaceutical industry and improve healthcare outcomes.
The article does not specify who is directly affected.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, signaling investor interest in applying AI to life sciences. This development has significant implications for the pharmaceutical industry and AI startups.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, signaling investor interest in applying AI to life sciences. This development has significant implications for the pharmaceutical industry and AI startups.
The article does not specify who is directly affected.
Miles Wang, an OpenAI researcher, is in talks to launch an AI drug discovery startup valued at $2B, signaling investor interest in AI-driven life sciences breakthroughs. This development could revolutionize the pharmaceutical industry and transform the future of healthcare.
Miles Wang, an OpenAI researcher, is in talks to launch an AI drug discovery startup valued at $2B, signaling investor interest in AI-driven life sciences breakthroughs. This development could revolutionize the pharmaceutical industry and transform the future of healthcare.
The article does not specify who is directly affected.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, signaling significant investor interest in applying AI to life sciences. This development marks a crucial milestone in the intersection of AI and healthcare.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, signaling significant investor interest in applying AI to life sciences. This development marks a crucial milestone in the intersection of AI and healthcare.
The article does not specify who is directly affected.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, marking a significant investment in applying AI to life sciences. This development highlights the growing interest in leveraging AI for breakthroughs in the pharmaceutical industry.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, marking a significant investment in applying AI to life sciences. This development highlights the growing interest in leveraging AI for breakthroughs in the pharmaceutical industry.
The article does not specify who is directly affected.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, signaling investor interest in AI life sciences. This development highlights the potential of AI in revolutionizing healthcare and pharmaceuticals.
OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup valued at $2B, signaling investor interest in AI life sciences. This development highlights the potential of AI in revolutionizing healthcare and pharmaceuticals.
The article does not specify who is directly affected.
Lorde recently expressed her concerns about AI glasses, stating they are 'not sexy' and highlighting the increasing difficulty in distinguishing reality from AI-generated content. This criticism comes amidst significant developments in AI technology, including OpenAI's upcoming smart speaker and controversies surrounding AI-powered layoffs.
Lorde recently expressed her concerns about AI glasses, stating they are 'not sexy' and highlighting the increasing difficulty in distinguishing reality from AI-generated content. This criticism comes amidst significant developments in AI technology, including OpenAI's upcoming smart speaker and controversies surrounding AI-powered layoffs.
The article does not specify who is directly affected.